Selected Abstracts
Dialysis, Chronic Renal Failure
Vascular Access: graft/fistula
d 
The relation of brachial artery flow to access flow
d
The relation of recirculation to access flow
d
The relation of intra-access pressure to intra-access flow
d
Do patients with angiographically proven access stenosis have low
access blood flow?
d
Access blood flow measurements in the low flow range by an
ultrasonic device are accurate
d
A new, Fick-principle based method for measuring blood flow in
hemodialysis grafts validated by magnetic resonance angiography
d
Access recirculation by ultrasonic dilution compared to a 20
sec slow flow method
d
Simplified accurate measurement of access recirculation with an in-
line hematocrit device
d
Extracorporeal venous drip chamber pressure measurement screening does
not predict impending hemodialysis access graft failure
d
Increasing AV fistulas for hemodialysis access
d
Measurement of access flow by thermodilution: in vitro experiments
d
Mutation at Arg506 of coagulation factor V and access
thrombosis in hemodialysis patients
d
The efficacy and complications of aspirin versus heparin in
post-operative prophylaxis against thrombosis in newly placed
hemodialysis access
Vascular Access: venous
d
Blood recirculation in central temporary catheters for acute
hemodialysis
Dialyzers
d
In vitro clearance of advanced glycosylated end-products by
conventional and high flux hemodialysis membranes
Complications (acute)
d
The protective effect of cool dialysate is dependent on patients'
predialysis body temperature
d
Relationship between blood volume and inferior cava diameter during
and after short and long hemodialysis
d
The intradialytic effects of oral L-carnitine: results of a
double blind placebo controlled trial
Dialysis machines
d
Safety of hemodialysis machines: Surveillance of the venous blood
return
Home hemodialysis
d
Long-term combination home automated peritoneal dialysis and in-center
hemodiafiltration for progressive neuropathy in end stage renal
disease
Adequacy, prescription, urea kinetics
d
Screening for extreme postdialysis urea rebound using the Smye
method
d
Cardiac index affects urea rebound to the extent predicted by
the regional blood flow model
d
Effect of intradialytic exercise on urea kinetics and rebound
d
Intradialytic exercise increases effective dialysis efficiency and
reduces rebound
Physiology
d
Fluctuations of urea generation rate following protein intake
in hemodialysis patients measured using [13-C]-urea
Reuse, theory and practice
d
Heat sterilization of dialyzers: maximized reuse with 1.5% citric
acid and 95 degrees C
d
Effect of Renalin reprocessing on small and large solute
clearances by hemodialyzers
Cardiovascular/Hypertension
d
Hypoalbuminemia: a major risk factor for cardiac disease in
ESRD
d
Hypertension, cardiomyopathy, cardiac morbidity and mortality in ESRD
d
Increased homocysteine values, a risk factor for premature coronary
artery disease, prevail in patients on hemodialysis
d
The effect of fluid loading on blood pressure in hemodialysis
patients
d
Arteriosclerosis, not atherosclerosis is common in end-stage renal
disease: related factors
d
Sudden cardiac death and autonomic nerve dysfunction in
hemodialysis patients
d
Effect of blood pressure on survival in a prevalent cohort of
hemodialysis patients
GI/Liver, Hepatitis
d
Long-term virological response after alpha-interferon therapy in HCV-
positive hemodialysis patients
d
Trends in the incidence of hepatitis C infection in hemodialysis units
d
Dialysis room and reuse strategies that affect the incidence of
hepatitis C infection in HD units
d
Beta-2-microglobulin amyloidosis involving the GI tract in
hemodialysis
Neurological
d
Severe neuropathy predicts mortality in non-diabetic dialysis
patients
Anemia/Erythropoietin/Iron
d
Role of endogenous erythropoietin in the hematopoietic response to
iron administration in hemodialysis patients
d
Interferon-gamma mediates resistance to erythropoietin in
uremic patients with inflammatory disease
d
Response to iron dextran therapy is not precluded by high serum
ferritin
d
Endogenous erythropoietin levels are elevated in patients on
continuous ambulatory peritoneal dialysis
d
Factors predictive of suboptimal iron stores in hemodialysis patients
with normal iron indices
d
Amelioration of left ventricular hypertrophy in long-term hemodialysis
patients
d
Effect of chronic human erythropoietin therapy on immune
response in chronic hemodialysis patients
d
Cell therapy for erythropoeitin-deficient anemias
d
Underdialysis impairs response to erythropoietin in
hemodialysis patients
d
Low iron absorption in erythropoietin-treated haemodialysis
patients
d
Can the erythropoietin dose be lowered safely? A case-control study of
subcutaneous administration
d
The safety and efficacy of intraperitoneal erythropoietin in
children on CCPD
d
Correction of anemia does not improve growth or endocrine function
in children with ESRD: A report from the U.S. multicenter pediatric
recombinant erythropoietin study
d
Comparison of 3 iron dextran infusion methods to correct anemia in
erythropoietin treated hemodialysis patients
Bone disease/aluminum
d
High phosphorus directly simulates PTH secretion by human
parathyroid tissue
d
Bone mineral loss in chronic renal failure: a difference between young
and old CRF patients
d
Low-dose DFO treatment (5 mg/kg) in acutely aluminum
intoxicated dialysis patients using two drug administration schedules
d
Expression in pathalogic parathyroid tissue of calcium receptor and
vitamin D receptor gene message
d
Expression of Bcl-2 oncoprotein in parathyroid tissue of patients with
primary and secondary hyperparathyroidism
d
Calcium-regulated parathyroid hormone release before and after
successful long-term calcitriol therapy in secondary
hyperparathyroidism
d
Non-suppressible parathyroid hormone secretion is related to
parathyroid gland size in uremic secondary hyperparathyroidism
d
Serum phosphorus strongly correlates with PTH in mild chronic renal
failure
d
Suppression of PTH by 22-oxacalcitriol in hemodialysis patients with
secondary hyperparathyroidism
d
Marked expression of c-fos/jun proteins in hyperplastic parathyroid
glands
d
Mild osteodystrophy: Is it really a mild disease?
d
Nasal calcitonin reduces bone loss in renal transplant
recipients
d
Effect of aging on renal responsiveness to parathyroid hormone
in healthy men
d
In vivo effect of intravenous 1,25-dihydroxyvitamin D3 on
interleukin-2 production in hemodialysis patients
d
Serum parathyroid hormone levels as a peredictor of the skeletal
resopnse to intermittent calcitriol therapy
d
Phosphate restriction prevents parathyroid cell growth in uremic rats
and high phosphate directly stimulated PTH secretion in tissue culture
d
Secondary hyperparathyroidism complicated by parathyromatosis
d
Monoclonal proliferation of nodues in parathyroid hyperplasia
due to chronic renal failure
d
Vitamin D receptor gene polymorphism and severity of secondary
hyperparathyroidism
CRF and diabetes
d
Depletion of advanced glycated end-products (AGEs) in uremic serum and
dialysis fluid by an AGE-binding lysozyme-matrix
Infections (other than hepatitis, peritonitis)
d
Hepatitis C viral infection and HIV co-infection in
hemodialyzed patients
d
Access-related infection in HIV-seropositive dialysis patients:
comparison of hemodialysis to peritoneal dialysis
d
Preoperative vancomycin prophylaxis decreases the incidence of
hemodialysis vascular access infections
Nutrition
d
Increased dialysis prescription improved nutrition
d
Can we reconcile metabolic acidosis and nutritional status in
hemodialysis patients?
d
Elevated serum C-reactive protein is a strong predictor of
increased mortality and low serum albumin in hemodialysis patients
d
Lean body mass estimation by different techniques in healthy controls
and peritoneal dialysis patients
d
Dialysis adequacy and nutrition in CAPD: a prospective study
d
Use of a 1.1% amino acid dialysis solution to treat
malnutrition in peritoneal dialysis patients
d
Linkage between adequacy of dialysis and nutrition in CAPD patients
d
Predictors of malnutrition in maintenance hemodialysis patients
d
Effect of insulin-like growth factor 1 on nitrogen balance in
malnourished CAPD patients
Outcomes (Morbidity, Mortality)
d
Residual renal function in hemodialysis and continuous ambulatory
peritoneal dialysis patients
d
High cytokine levels may mediate the high mortality of
hemodialysis patients with low albumin and cholesterol
d
Patient survival on CAPD: comparison between Canada and the United
States
d
Cardiac disease in endstage renal disease: A comparison of
hemodialysis and peritoneal dialysis
d
Comparison of mortality risk by Kt/V single pool vs. double pool
analysis in diabetic and non-diabetic dialysis patients
d
Effect of serial APACHE and organ failure scores on prediction of
mortality in acute renal failure
d
Association of serum bicarbonate to survival in hemodialysis: a
non-linear relationship
d
Early death in dialysis patients: risk factors and impact on incidence
and mortality rates
d
Predictors of short-term mortality in diabetic hemodialysis
patients
Complications of PD
d
Increased risk of adverse outcome in immunosuppressed patients
undergoing CAPD
PD solutions, equipment
d
Effect of amino acid based dialysate on peritoneal blood flow and
permeability during CAPD
d
CAPD using a self-made, ultrafiltration-sterilized, bicarbonate-based
solution
PET testing
d
Correlation between peritoneal transport type and peritoneal
protein losses
Physiology
d
Pressure causes fluid loss from the peritoneal cavity to the
body
d
Effect of acutely raising the serum albumin on peritoneal transport
and ultrafiltration in CAPD patients
Peritonitis and exit-site infection
d
Bacteria grow better if pH of CAPD solutions is elevated from
5.0 to 6.4, offsetting improvement in neutrophil phagocytosis
d
Peritonitis influences mortality in PD patients
Chronic PD regimens, adequacy, modeling
d
The creatinine excretion ratio is an unreliable indicator of non-
compliance in PD patients
d
Urea and weekly creatinine clearances measured by direct
quantification: Comparison in APD, CAPD, and conventional HD
d
Formula to calculate nitrogen losses in patients treated with chronic
peritoneal dialysis
d
Comparison of 2 year survival on hemodialysis and peritoneal dialysis
with dose of dialysis matched using the peak concentration hypothesis
d
Association between adequacy and nutrition in CAPD -- genuine or
artifact?
Etiology
d
Attribution of hypertension as the underlying cause of ESRD: does
race matter?
d
Low birth weight a risk factor for development of diabetic
nephropathy?
Progression
d
ACE gene polymorphism and progression of renal disease
d
Urinary transforming growth factor beta-1 and progression of
glomerular diseases
d
Magnitude of end-stage renal disease in IDDM: 35 year follow-up
study
d
Effect of dietary protein restriction on the progression of non-
diabetic renal disease: meta-analysis
Continous therapies
d
Limiting continuous venovenous hemofiltration in acute renal failure
d
Treatment of volume overload in patients with acute renal
failure by intermittent hemodialysis
d
Microspheres for specific adsorption as supplement for hemodialysis in
acute renal failure
d
Cytokine removal and cardiovascular hemodynamics in patiens
with ARF and treatment with CVVH
d
Incidence of hypothermia during continuous renal replacement
therapy
d
Bicarbonate dialysate for continuous renal replacement therapy
d
Continuous veno-venous hemodialysis in septic patients
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.